Samrat Pharmachem Limited (SAMRATPH.BO)
Samrat Pharmachem Limited operates in the Chemicals - Specialty industry of the Basic Materials sector, headquartered in Mumbai, MA, IN. The stock last traded at $231.20, down 3.81% on the session, giving a market capitalisation of $714.3M. Its beta of -0.23 implies it has historically moved less than the broad market.
Samrat Pharmachem Ltd. is a company focused on the production and sale of various chemical compounds. Its product offerings feature substances like 3-5–Di iodosalicylic acid, aluminium iodide, clioquinol, ethylenediamine dihydroiodide, copper iodine, and lithium iodide. Lalit Damodar Mehta founded the enterprise on June 16, 1992, and it maintains its primary offices in Mumbai, India.
Samrat Pharmachem Limited is most often compared with the following Basic Materials names: